HappyTidy on BIOCOMPUTER

Itzhak Bentov: The Proto-Biocomputer Theorist Who Got There 50 Years Early

Sun, 12 Apr 2026 00:00:00 +0000

In 1977, an engineer with no formal academic degree published a book that described the human body as a piece of hardware, consciousness as software, and meditation as a system optimization routine. The book was Stalking the Wild Pendulum. The author was Itzhak Bentov — inventor, mystic, and arguably the first person to think seriously about biology as computation.

Bentov died two years later in the 1979 American Airlines Flight 191 crash. He never saw the field of biocomputing emerge. But reading his work in 2026, against the backdrop of Cortical Labs’ CL1 chips and FinalSpark’s Neuroplatform, something uncomfortable becomes clear: he was pointing at the right problem, with the wrong vocabulary, at exactly the right time.

At BioComputer we don’t traffic in mysticism. But we do pay attention when an engineer’s framework — however unconventional — maps cleanly onto where biology-as-computation is actually going.

AlphaFold's Interactome Leap: 1.7 Million AI-Predicted Protein Complexes, Free for Everyone

Fri, 10 Apr 2026 00:00:00 +0000

When AlphaFold dropped its 200-million-protein database in 2022, it felt like the end of something — the long slog of experimental structure determination, at least for individual proteins. It wasn’t the end. It was a setup. Because proteins don’t work alone, and everyone in the field knew the real problem was always the interactions. On April 10, 2026, EMBL-EBI, Google DeepMind, NVIDIA, and the Steinegger Lab at Seoul National University answered that problem with a single release: 1.7 million high-confidence AI-predicted protein complexes, integrated directly into the AlphaFold Database, free for anyone on earth to use.

This is the interactome era of computational biology. Not predicting what a protein looks like — predicting what it does with others.

The implications run from basic science straight into drug discovery, host-pathogen research, and the next generation of AI protein design tools. The barrier to proteome-scale interaction studies just dropped through the floor.

Frog Cells Don't Wait for Code — They Wire Their Own Brains

Fri, 10 Apr 2026 00:00:00 +0000

In 2020, Michael Levin’s team at Tufts University sculpted the first xenobots—tiny living machines made entirely from frog embryonic cells that could swim, heal themselves, and even replicate.

Six years later, the same cellular playbook has produced something far more sophisticated. Researchers implanted early-stage neural precursor cells into these cellular clusters. The nerve cells didn’t wait for external scaffolding or silicon instructions—they spontaneously matured, extended axons and dendrites, and wired themselves into a functional, electrically active network.

Biology just designed its own nervous system inside a machine it built from scratch.

The tension is stark. Earlier biobots moved via cilia or muscle but lacked any centralized internal control. These new neurobots navigate with purpose, show dynamic trajectories, and reshape their own anatomy through the very circuitry they grew.

This isn’t an upgrade. It’s proof that biological computation can bootstrap its own hardware—turning wetware into the ultimate self-programming substrate.

All Biology Is Computational Biology — But Now Biology Is the Computer

Thu, 09 Apr 2026 00:00:00 +0000

In March 2017, Florian Markowetz published a manifesto in PLOS Biology: all biology is computational biology. He showed how databases, mutational signatures, Next Generation Sequencing alignment, and quantitative maps of tumor heterogeneity turned fuzzy biological ideas into rigorous, testable science. Computation did not just assist biology — it reordered it.

Nine years later the thesis stands — and then gets surpassed.

We no longer run silicon code about biology. We grow living processors that are the code. Biology as computation has completed the inversion. The next modern synthesis is not training biologists to code. It is engineering cells, organoids, and gene circuits that compute natively in chemical space.

Electronic Skin That Thinks: How Cambridge's Conductive Hydrogel Is Rewriting Robotic Touch

Thu, 09 Apr 2026 00:00:00 +0000

In 2025, a team at the University of Cambridge and University College London published something that sounds deceptively simple: a robotic glove made from conductive gelatin. What David Hardman, Thomas George Thuruthel, and Fumiya Iida actually built is far more interesting — a multi-modal sensing system that processes over 860,000 distinct signal pathways from just 32 electrodes at the wrist. That’s not a sensor. That’s a network.

The paper, published in Science Robotics, frames this as a tactile problem. But read it closely and you see the deeper question: what if sensing isn’t about placing sensors in the right spots — what if the material itself is the computation?

That reframe is why this matters to anyone watching the convergence of biology and computation. Skin doesn’t compute the way silicon does. It computes the way a distributed biological system does — through pattern, redundancy, and emergent signal processing across a medium that is simultaneously structural and informational.

1.14 Billion Rows of Psychiatric DNA — Now One Line of Python Away

Wed, 08 Apr 2026 00:00:00 +0000

On April 7, 2026, Maziyar Panahi of OpenMed_AI posted what might be the most consequential single data release in computational psychiatry this year. Every GWAS summary statistic ever published by the Psychiatric Genomics Consortium — 1.14 billion rows, 52 publications, 12 major disorder groups — is now sitting on Hugging Face in clean Apache Parquet format, queryable with a single line of Python.

Before this, accessing PGC data meant chasing scattered Figshare links, wrangling inconsistent column separators, and running wget | gunzip | awk pipelines for each of 52 datasets. Researchers weren’t doing science. They were doing plumbing.

The barrier wasn’t intellectual. It was logistical. And OpenMed_AI just demolished it.

AlphaGenome: DeepMind's AI Decodes the 98% Non-Coding Genome, Supercharging CRISPR for Genetic Diseases

Wed, 08 Apr 2026 00:00:00 +0000

On April 7, 2026, Demis Hassabis explained publicly why CRISPR — despite being able to target nearly any DNA sequence — still struggles to cure most genetic diseases: we don’t know which mutation is actually driving the problem, especially in the 98% of the genome that doesn’t code for proteins.

That’s the bottleneck. Not the scissors. The map.

Enter AlphaGenome, DeepMind’s new unified DNA sequence model. It takes up to 1 megabase of raw DNA and predicts thousands of functional genomic tracks at single-base-pair resolution — reliably flagging which non-coding variants are likely driving disease. CRISPR just got a targeting system worthy of it.

MaxToki: Temporal AI Trained on 175 Million Cells Predicts How to Rejuvenate Aging Cell States

Wed, 08 Apr 2026 00:00:00 +0000

On April 6, 2026, David Sinclair highlighted a new preprint that brings AI directly into the heart of cellular aging. Researchers at Gladstone Institutes, in collaboration with NVIDIA and others, have built MaxToki — a temporal AI foundation model trained on massive single-cell gene expression data spanning the entire human lifespan.

The model doesn’t just observe how cells change with age. It learns the trajectories of cell states over time and predicts perturbations that can restore youthful identity. Experimental validation in vivo already shows the predicted targets influence age-related gene programs and functional decline.

This is biology meeting modern foundation modeling at scale.

NASA's AVATAR: Personalized Bone-Marrow Biocomputers Are Flying to the Moon on Artemis II

Tue, 07 Apr 2026 00:00:00 +0000

As the four Artemis II astronauts circle the Moon on their 10-day test flight this month, they aren’t the only passengers collecting data. Riding alongside them inside the Orion spacecraft are four USB-sized organ-on-a-chip devices — each built from the crew’s own bone-marrow cells, each running the same gauntlet of cosmic radiation and weightlessness as the humans who donated them.

These aren’t passive sensors logging temperature or pressure. They are living biological computers — personalized tissue analogs designed to capture, at single-cell resolution, exactly how each astronaut’s immune system and blood-forming machinery respond to the most hostile environment our species has ever entered.

This is NASA’s AVATAR investigation — A Virtual Astronaut Tissue Analog Response — and it is one of the clearest demonstrations yet that programmable biology is no longer a lab curiosity. It’s flight hardware.

The Price Is Not Right: Why Symbolic Reasoning Beats Foundation Models in Robotics

Tue, 07 Apr 2026 00:00:00 +0000

Neuro-Symbolic AI Beats Foundation Models with 100x Less Energy: Lessons for Biohybrid Computing

In February 2026, a four-person team at Tufts University’s Human-Robot Interaction Lab published a result that should unsettle anyone who has bet on foundation models as the universal answer to embodied AI. Timothy Duggan, Pierrick Lorang, Hong Lu, and Matthias Scheutz ran a head-to-head comparison between a fine-tuned open-weight Vision-Language-Action model (π₀) and a neuro-symbolic architecture on structured long-horizon manipulation tasks. The neuro-symbolic system won — not narrowly, but comprehensively, on every metric that matters: accuracy, generalization, training time, and energy consumption.

The benchmark was the Tower of Hanoi puzzle. Deceptively simple to describe, structurally brutal to plan. Three blocks, a set of inviolable rules, a sequence of moves that must be computed rather than guessed. The VLA model managed a 34% success rate on the 3-block version. The neuro-symbolic architecture hit 95%. On an unseen 4-block variant that neither system had trained on, the VLA failed every single attempt. The hybrid system succeeded 78% of the time.

That asymmetry is the thesis. Biology has spent 600 million years evolving nervous systems that combine pattern recognition with rule-based reasoning. The AI field spent a decade betting that scale alone could replicate that. The Tufts paper, accepted at ICRA 2026 in Vienna, is empirical evidence that this bet has a cost — and the cost is now measurable in kilowatt-hours.

Tohoku's Living Neurons Just Ran Real Machine Learning — and Won

Mon, 06 Apr 2026 00:00:00 +0000

In March 2026, Hideaki Yamamoto’s team at Tohoku University and Future University Hakodate did something that should change how you think about machine learning. They wired cultured rat cortical neurons through a 26,400-electrode high-density microelectrode array, applied FORCE learning — the first-order reduced and controlled error algorithm — and watched living brain cells generate clean sine waves, triangular waves, square waves, and full Lorenz attractor trajectories on demand.

This is not a simulation. Not a metaphor. Rat neurons stopped firing random bursts and started executing temporal pattern generation tasks that trip up silicon systems at scale. The closed-loop feedback cycle ran at 332.5 ± 1.5 ms. The networks held their output autonomously after feedback stopped.

The thesis is simple and irreversible: living neural networks are programmable computational substrates. Wetware just crossed into supervised AI territory.

China's Carbon Era: How Beijing Is Betting on Brains and Biology to Win the Compute War

Sun, 05 Apr 2026 00:00:00 +0000

In March 2026, China’s National Medical Products Administration did something no regulatory body had done before: it approved an invasive brain-computer interface for commercial sale. Not a clinical trial. Not a compassionate use exemption. A product. On the market. Now.

The device — from Neuracle Medical Technology in Shanghai — lets patients with tetraplegia regain hand motor function through a fully wireless, AI-decoded implant system. The West is still debating the ethics. China shipped the product.

This is the carbon era. And China just declared it open for business.

China's First Commercial BCI Is a Wake-Up Call for the Brain-as-Computer Era

Sun, 05 Apr 2026 00:00:00 +0000

On March 13, 2026, China’s National Medical Products Administration granted the world’s first commercial approval for an invasive brain-computer interface. The device is called NEO — a coin-sized wireless implant developed by Shanghai-based Neuracle Medical Technology in collaboration with Tsinghua University, placed epidurally on the brain’s outer membrane. When a patient imagines moving their hand, NEO reads the motor cortex signal and wirelessly drives a soft robotic glove to grasp, hold, and manipulate objects. Target users: adults aged 18–60 with partial paralysis from cervical spinal cord injuries.

This is not a clinical trial. NEO is a commercial medical product — cleared for sale, surgical implantation, and real-world clinical use in Chinese hospitals today.

In one regulatory stroke, BCIs moved from experimental labs into everyday medicine. The brain-as-computer era has officially begun — and China fired the starting gun.

Gratitude Journaling Rewires the Brain: The Natural Firmware Update for Your Biological Computer

Sun, 05 Apr 2026 00:00:00 +0000

The viral claim is surprisingly well-supported: write down three specific things you’re grateful for — with explanations — every day for 8 weeks, and you’ll produce measurable structural changes in your brain. Stronger connections between the hippocampus and the ventral tegmental area (VTA). Increased gray matter density. New synaptic connections forming after just 4–6 weeks.

That’s not motivational content. That’s neuroplasticity in action.

The human brain rewires itself based on repeated input. Run the same signal through the same circuit often enough, and the circuit strengthens — this is Hebbian learning, summed up cleanly as “neurons that fire together, wire together.” Consistent gratitude practice is, mechanically speaking, a daily firmware update for your biological computer. And the fMRI data backs it up.

One Injection Rewrites the Inner Ear's Code — Hearing Restored in Every Patient

Sun, 05 Apr 2026 00:00:00 +0000

In April 2026, a team from Karolinska Institutet and partner hospitals across China injected a synthetic virus carrying a working copy of the OTOF gene straight into the cochlea of ten patients born deaf. Every single one started hearing again. Average detection threshold dropped from 106 dB to 52 dB. A seven-year-old girl went from profound deafness to holding conversations with her mother in four months.

This wasn’t a cochlear implant. This wasn’t training the brain around the damage. This was a one-shot firmware update to biological hardware that had been running broken code since birth.

Biology is now programmable — and the inner ear just proved it at clinical scale.

AI Co-Scientists Are Now Doing Cancer Research — Not Just Analyzing It

Fri, 03 Apr 2026 00:00:00 +0000

Cancer research has always been a war of attrition — billions spent, decades consumed, hypotheses that collapse in clinical trials after years of promise. In 2026, something fundamental is shifting. Agentic AI platforms aren’t waiting to be asked a question. They’re generating the questions themselves.

The April 2026 issue of Cancer Discovery formalized what many labs had been quietly witnessing: AI systems have crossed from passive data interpretation into active scientific collaboration. These aren’t chatbots that summarize papers. They’re co-scientist architectures — multimodal, multistep reasoning engines that propose drug targets, plan experimental sequences, and increasingly interface with physical lab automation. The American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego (April 17–22) dedicates multiple plenary sessions to this shift, treating it not as a future possibility but as present-tense infrastructure.

The question is no longer whether AI can help scientists. It’s whether the scientist is now partly redundant in the loop — and what that means for the biology we trust.

AI Masters the Grammar of Bacterial Immunity — 2.39 Million Programmable Defense Systems Just Became Readable

Fri, 03 Apr 2026 00:00:00 +0000

In 2026, Ernest Mordret and colleagues at the Institut Pasteur trained three complementary transformer models on 123 million bacterial proteins drawn from 32,000 genomes.

What they uncovered is staggering: bacterial immunity is far larger, more diverse, and more computationally elegant than anyone realized. Fewer than 250 antiphage systems had ever been experimentally validated. The new atlas contains 2.39 million predicted antiphage proteins. Roughly 1.5% of a typical bacterial genome is now understood to be defense infrastructure—three times previous estimates. More than 85% of the predicted protein families had no prior link to immunity whatsoever.

The tension is obvious: we thought we had mapped bacterial defense. We had barely scratched the surface. The payoff is immediate. Language models just turned the bacterial pangenome into an actionable, programmable resource for next-generation synthetic biology.

DNA Origami Nanorobots: Programmable Molecular Biocomputers in the Bloodstream

Fri, 03 Apr 2026 00:00:00 +0000

In 2025, a team spanning Ludwig-Maximilians-Universität München, Emory University, and Georgia Tech published something that quietly redrew the boundaries of what “computer” can mean. Their spring-loaded DNA origami arrays — published in Science Robotics — didn’t just carry a payload. They stored energy, processed multiple molecular signals, and executed multistep tasks without any external controller. The machine was the biology. The biology was the machine.

This is DNA origami nanorobotics: the art of folding long DNA scaffolds into precise 3D structures using hundreds of short “staple” strands, then programming those structures to behave like autonomous decision-making systems at the nanoscale. The shapes range from hollow barrels to spring-loaded hinges, and the logic runs on strand displacement reactions — the same base-pairing rules that have governed genetic information for billions of years.

The hard question isn’t whether these nanorobots work. The 2025–2026 literature confirms they do. The question is what it means when the most sophisticated computers on Earth are made of the same material as your chromosomes — and they swim in your veins.

Epia Neuro's Skull Implant and AI Glove Want to Give Stroke Survivors Their Grip Back

Fri, 03 Apr 2026 00:00:00 +0000

Two-thirds of stroke survivors never fully regain hand function. Not because the intent to move disappears — in many patients, the brain still fires the signal — but because the pathway between intent and muscle has been severed or damaged. For decades, rehabilitation has meant repetition therapy, hoping the brain rewires itself fast enough before the recovery window closes around the six-month mark. Michel Maharbiz, Ph.D., founder of iota Biosciences and former UC Berkeley professor, thinks the window can be forced open with the right hardware.

On April 2, 2026, his company Epia Neuro emerged from stealth with a system that pairs a disk-shaped skull implant with an AI-guided motorized grip glove. The goal isn’t to build a permanent prosthetic bypass. It’s to use the device itself to drive neuroplasticity — strengthening the brain’s own motor pathways until the patient no longer needs the glove at all.

That’s a fundamentally different bet from the rest of the BCI field, and it might be the right one.

Wetware Is the New Prime Real Estate: Why Biocomputing Will Define the Intelligence Economy

Fri, 03 Apr 2026 00:00:00 +0000

In the SaaS era, competitive advantage came from better code, bigger clouds, and user lock-in. That world is fading fast. As foundation models become widely accessible and AI agents proliferate, every company can build or buy comparable intelligence. The war for differentiation is shifting to a single metric: who can deliver the most useful intelligence output while consuming the least energy?

The answer, increasingly, is not found in silicon. The human brain performs sophisticated cognition on roughly 20 watts. Today’s leading AI clusters require megawatts for comparable operations — a gap estimated at 100,000× to 1,000,000× in energy efficiency. That gap is not a rounding error. It is the central economic fact of the next decade.

The most valuable “digital real estate” of the 2030s will be proprietary wetware — patented biological architectures — paired with energy-efficient bio-infrastructure. Biology already solved the efficiency problem. The intelligence economy is only now catching up.

What Are Customers Doing with the World's First Commercial Biocomputer?

Fri, 03 Apr 2026 00:00:00 +0000

When Cortical Labs shipped the first CL1 units in 2025, it wasn’t just a product launch — it was the opening of a new chapter in what computation can be. A box containing up to 800,000 living human neurons, interfaced with silicon, learning in real time, drawing just 30 watts. That’s not a GPU. That’s not even close.

The question that followed wasn’t can biology compute. The answer to that has been yes for three billion years. The question was: what do you actually do with it once you can buy one?

At $35,000 per unit, the CL1 sits firmly in research territory — not consumer electronics, not enterprise IT. The buyers are labs, universities, and biotech companies willing to work at the frontier. And what they’re building with living neurons is more varied — and more consequential — than most people expect.

30 Million Cells, One Blueprint — Johns Hopkins Maps the Code of Human Thought

Tue, 31 Mar 2026 00:00:00 +0000

In 2026, Johns Hopkins researchers working with the BRAIN Initiative Cell Atlas Network delivered what single labs could not: a unified cellular atlas of the developing human neocortex built from nearly 200 published studies and more than 30 million cells.

The data always existed in fragments. Scattered across papers, different methods, varying time points. The full developmental program of biology’s most sophisticated computer remained hidden in the noise.

No longer. This neocortex atlas doesn’t just describe cells. It reveals the precise genetic programs and cellular transitions that transform neural stem cells into the layered architecture responsible for thought, sensation, memory, and decision-making.

The History of Biocomputing: From Philosophical Wetware to Living Computers

Tue, 31 Mar 2026 00:00:00 +0000

In 1968, neuroscientist John C. Lilly published Programming and Metaprogramming in the Human Biocomputer, framing the mind as programmable biological hardware. Decades later, in 2025, Cortical Labs released the CL1 — the world’s first commercial biological computer, built with 800,000 living human neurons cultured on a silicon chip and priced at around $35,000.

Silicon still rules. Yet biology — refined over billions of years — offers massive parallelism, self-repair, and energy efficiency that current chips cannot match. A human brain runs on roughly 20 watts; data centers gulp megawatts. The tension is clear: traditional computing hits physical walls while biocomputing turns living systems into programmable hardware.

Biology as computation is no longer metaphor. It is becoming engineering reality.

Artificial Biological Intelligence: Writing Life from Scratch in the Post-Darwinian Era

Mon, 30 Mar 2026 00:00:00 +0000

Evolution is a terrible programmer. It accumulates 3.8 billion years of patches, dead code, and workarounds — what Adrian Woolfson calls “spaghetti code” — because it cannot plan ahead. It only keeps what survives. In March 2026, Woolfson joined physician-scientist Eric Topol on the Ground Truths podcast to argue that this constraint is ending. The age of Artificial Biological Intelligence (ABI) — designing and booting up entirely new genomes using AI — has begun, and it changes everything about how we think about biology as an engineering substrate.

Woolfson’s book, On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, April 28, 2026), frames this as biology’s biggest phase transition since Watson and Crick. We moved from reading genomes (Sanger sequencing), to editing them (CRISPR), to now writing them from scratch. That third phase — authoring — is what ABI unlocks.

For biological computing, the implications are not peripheral. They are foundational. If you can design a genome, you can design a genome optimized for computation.

Neuromorphic vs. Wetware: Two Paths to Brain-Inspired Intelligence

Mon, 30 Mar 2026 00:00:00 +0000

The computing world is hitting a wall that no roadmap can paper over. Training a frontier AI model now consumes energy equivalent to powering hundreds of households for months. Meanwhile, sitting three pounds inside your skull, the human brain delivers flexible, context-aware intelligence on roughly 20 watts — the output of a dim light bulb. That gap isn’t a design flaw. It’s an indictment of how we’ve been building computers.

Two approaches have emerged to close it. Neuromorphic computing reimagines silicon to behave like neural tissue. Wetware — biological computing — skips the simulation entirely and uses actual living neurons as the substrate. They share the same inspiration: the brain. But they take fundamentally different routes, carry different trade-offs, and increasingly, they’re converging into hybrid systems that neither camp anticipated.

Understanding both isn’t just an academic exercise. It’s a map of where intelligence itself is heading.

Fractal Minds and the Biocomputing Substrate: What Judah Anttila's TEDx Talk Gets Right About 2026–2045

Sun, 29 Mar 2026 00:00:00 +0000

In January 1999, Ray Kurzweil published The Age of Spiritual Machines and predicted AGI by 2029. Twenty-seven years later, that date is no longer fringe — it’s a consensus target. Judah Anttila’s 2024 TEDxOU talk doesn’t just cite Kurzweil; it absorbs him, strips away the technical jargon, and lands on something harder to dismiss: a fractal mind thesis — the idea that consciousness is a pattern, not a substrate, and that it can ingest into software, mathematics, wetware, or all three simultaneously.

Watch the full 16-minute talk before reading further — the argument builds fast, and the emotional register matters:

What Anttila describes isn’t simply silicon AI replacing jobs or nanobots buying us extra decades. It’s a convergence event — biology and computation collapsing into each other until the distinction becomes meaningless. That’s precisely the territory biocomputer.com was built to cover. And the 2026 data, examined closely, makes his case more urgent than his timeline suggests.

Meta's TRIBE v2 is not a Biocomputer — but it could make biocomputers 10x better

Sat, 28 Mar 2026 00:00:00 +0000

On March 26, 2026, Meta’s Fundamental AI Research (FAIR) team quietly released something that deserves far more attention from the biocomputing world than it has received. TRIBE v2 — the TRImodal Brain Encoder version 2 — is not a biocomputer. No living neurons are involved. No wetware. No perfusion systems. It runs entirely on silicon GPUs and predicts brain activity from fMRI scans at a resolution 70 times higher than its predecessor.

That distinction matters enormously. The biocomputing field has spent years arguing that living neurons are irreplaceable — that biological computation is fundamentally different from simulation. TRIBE v2 does not challenge that argument. What it does instead is something more immediately useful: it gives wetware researchers a virtual testbed to run thousands of experiments before a single neuron is plated on a chip.

The question worth asking is not whether TRIBE v2 is a biocomputer. It is whether TRIBE v2 could make real biocomputers — systems like Cortical Labs’ CL1 or FinalSpark’s Neuroplatform — arrive faster, work better, and cost less to iterate on.

Biohybrid Robots: When Machines Grow Their Own Muscles and Brains

Thu, 26 Mar 2026 00:00:00 +0000

In early 2026, University of Illinois Grainger engineers unveiled a crawling biohybrid robot powered by living mouse muscle tissue and controlled by genetically engineered neurons that form real neuromuscular junctions. Light pulses trigger the neurons, the muscles contract, and the two-legged skeleton moves forward — sometimes even continuing after the stimulus stops.

This isn’t science fiction. It’s the latest step in biohybrid robotics, where machines grow their own soft actuators and control systems from living cells instead of motors and rigid electronics.

At BioComputer we see these systems as the physical embodiment of biocomputing: living neurons and muscle tissue working together as a hybrid biological computer that senses, decides, and acts in the real world.

From Thought to Voice: Neuralink's VOICE Trial and the Emergence of the Living Biocomputer

Thu, 26 Mar 2026 00:00:00 +0000

In a quiet moment captured on video, Kenneth Shock looks directly at the camera and says, “I am speaking to you with my mind.”

What is a Biocomputer in 2026? The Full Landscape of Biology Meets Computation

Thu, 26 Mar 2026 00:00:00 +0000

In March 2025, Cortical Labs shipped the CL1 — the world’s first commercial biological computer built with real human neurons grown on silicon. One year later, they stacked 120 of those units into a biological data center prototype in Melbourne, with plans for up to 1,000 units in Singapore.

FinalSpark meanwhile gives researchers cloud access to hundreds of living brain organoids via simple Python code. At the same time, Neuralink has 21 human trial participants worldwide, with its new VOICE trial pushing toward conversational speech restoration.

The narrow definition of a biocomputer — using living neurons, organoids, DNA or proteins as the actual computing substrate — is expanding fast. At BioComputer we track the full convergence of biology and computation because that’s where the real momentum sits in 2026.

John C. Lilly and the Human Biocomputer: The Mind as Reprogrammable Software

Sat, 21 Mar 2026 00:00:00 +0000

In 1928, a sixteen-year-old boy in Saint Paul, Minnesota wrote a prep school essay titled “Reality.” In it, he puzzled over a single question: “How can the mind study itself?”

That boy was John Cunningham Lilly. The question would consume the next seven decades of his life — and quietly lay the intellectual foundation for everything we now call brain-computer interface science.

Proteome Complexity and Intelligent Organoids: Cracking the Next Bottleneck in Biocomputing

Sat, 21 Mar 2026 00:00:00 +0000

In 2026, biocomputing is no longer science fiction. Cortical Labs’ CL1 lets human neurons play DOOM in real time. FinalSpark sells remote access to wetware processors. DishBrain cultures master Pong faster than many AI models. At BioComputer we celebrate these breakthroughs — they prove biology can compute in ways silicon never will.

Yet one voice keeps ringing in our ears: Denis Noble’s 2024 Nature review of Philip Ball’s How Life Works. His verdict was blunt. “It’s time to admit that genes are not the blueprint for life.” As long as we insist cells are computers and genes are their code, Ball argues, “life might as well be sprinkled with invisible magic.” Nikolai Slavov echoed the warning in fresh 2025 proteomics work: the real unexplored frontier is not DNA — it’s the proteome.

If we want biocomputers that scale beyond impressive lab demos into reliable, industrial-grade wetware, we must confront the proteome bottleneck head-on. And when we do, the payoff is enormous — especially in drug discovery, where “thinking” organoids could collapse preclinical timelines by an order of magnitude.

The Cancer That Has No Name — And the AI That Finally Answers It

Fri, 20 Mar 2026 00:00:00 +0000

Imagine sitting in a hospital room and hearing your oncologist say: “We know you have cancer. We can see it has spread. But we don’t know where it started — and we may never find out.”

You Can Now Analyze Your Genome Just by Asking

Fri, 20 Mar 2026 00:00:00 +0000

For decades, making sense of biological data meant writing code. Not just a little code — thousands of lines of it, stitched together from a patchwork of incompatible tools, each with its own quirks, dependencies, and update schedules. If you wanted to analyze gene expression across different tissues, you needed to be as much a software engineer as a biologist.

A new system called OmicClaw, released as a preprint this week, is trying to change that. The idea is simple: what if you could analyze complex genomic data by just… asking for it in plain English?

DARPA Wants to Build a Biocomputer for the Battlefield

Thu, 19 Mar 2026 00:00:00 +0000

The fruit fly has around 140,000 neurons. Its brain consumes less than six milliwatt-hours of energy per day — roughly the same as leaving a single LED on for one minute. In that tiny biological package, a fly can navigate complex environments, detect smells across distance, avoid threats, and learn from experience.

When Does a Dish of Neurons Start to Matter?

Thu, 19 Mar 2026 00:00:00 +0000

A dish of human neurons learned to play Doom last year. It did so without being programmed, without training data, and without anyone telling it what winning looked like. It simply received feedback — signals that said, in the language of electricity, this worked and this didn’t — and it adapted.

Cortical Labs CL1 vs FinalSpark Neuroplatform: Head-to-Head in 2026 — Which Biocomputer Should You Use?

Wed, 18 Mar 2026 00:00:00 +0000

Cortical Labs and FinalSpark are no longer just lab experiments — they are the two commercial biocomputers you can actually use today.

Bioinformatics Has Entered Its Builder Phase — And Biology Will Never Be the Same

Fri, 13 Mar 2026 00:00:00 +0000

For decades, bioinformatics lived in the background — a support discipline that helped biologists manage data. In 2026, that story is over. The biocomputer era of biology is here, and it is moving fast.

You Can Rent Living Human Brain Cells as a Biocomputer — Right Now

Thu, 12 Mar 2026 00:00:00 +0000

Imagine running experiments on living human brain cells without a lab, without specialized equipment, and without a biology degree. Just a laptop and a Python script. That’s not a thought experiment — it’s a service you can sign up for today.

The World's First Biological Data Centers Are Running on Human Brain Cells

Wed, 11 Mar 2026 00:00:00 +0000

The server racks are silent. There are no fans spinning at 10,000 RPM, no GPU arrays drawing thousands of watts, no rivers of cooling water beneath the floor. Instead, inside two small facilities in Melbourne and Singapore, living human brain cells are processing information — and, according to their creators, doing it better than any silicon chip could hope to match on energy efficiency.

200,000 Human Brain Cells Just Learned to Play DOOM — and It Changes Everything About AI

Sun, 08 Mar 2026 00:00:00 +0000

In 2021, a team of Australian scientists spent 18 months teaching a cluster of human brain cells to play Pong.

The Companies Building the Biocomputer Era Right Now

Sun, 08 Mar 2026 00:00:00 +0000

The AI industry just spent two years building the most energy-intensive infrastructure in human history. Data centers drew over $200 billion in 2025. Training a single frontier model can consume as much electricity as a small city.

The AI Doctor in the Room: How Microsoft's MAI-DxO Outdiagnosed Human Physicians

Fri, 06 Mar 2026 00:00:00 +0000

In June 2025, Microsoft published research that quietly shook the medical world.

Your Body as Your Password: The Science and Future of Biometrics

Fri, 06 Mar 2026 00:00:00 +0000

Every morning, hundreds of millions of people unlock their phones by holding them up to their face. In airports across the world, travelers walk through gates that verify identity by scanning the pattern of their iris in under a second. In hospitals, patients are identified by their palm veins before receiving treatment. In some cities, cameras track individuals through crowds using gait recognition — the distinctive way a person walks — even when their face is obscured.

DNA Computing: When the Code of Life Becomes the Code That Computes

Thu, 05 Mar 2026 00:00:00 +0000

There is a computer inside every cell of your body. It has been running for roughly 3.8 billion years. It stores information at a density that makes the best flash drives look primitive. It repairs its own errors. It replicates itself. It runs on chemistry, requires no electricity, and operates in parallel across trillions of instances simultaneously.

How AI Is Reinventing Drug Discovery — From Guesswork to Precision

Thu, 05 Mar 2026 00:00:00 +0000

For most of human history, finding a new drug meant one thing: trial and error at massive scale. Chemists would synthesize thousands of molecules, test them against biological targets, discard the failures, tweak the survivors, and repeat — for years. The average journey from lab bench to pharmacy shelf took 12 to 15 years and cost roughly $2.5 billion. And despite all that time and money, more than 90% of drug candidates still failed in clinical trials.

When Brain Implants Become Medicine: How BCIs Are Treating Paralysis, Epilepsy, and Depression

Wed, 04 Mar 2026 00:00:00 +0000

In June 2025, five people with severe paralysis were using Neuralink implants to control digital devices with their thoughts. Not in a laboratory. Not as part of a carefully controlled experiment where every moment was monitored. In their lives — using brain signals to send messages, browse the internet, control wheelchairs.

Human Brain Cells on a Chip Are Now for Sale — The World's First Commercial Biocomputer

Sun, 15 Jun 2025 00:00:00 +0000

For decades, biocomputing existed only in academic papers and research lab demos. That changed in 2025.

What is a Biocomputer? A New Way to Think About Biology and Technology

Thu, 06 Mar 2025 00:00:00 +0000

When most people hear the word “computer,” they picture a metal box with a glowing screen, maybe a rack of servers humming in a data center. But there is another kind of computer that has been running for billions of years, one that fits inside a single cell and runs on chemistry instead of electricity. It is called a biocomputer, and understanding how it works is starting to reshape both biology and technology.

Neuralink Explained: What Happens When Your Brain Connects to a Machine

Tue, 04 Mar 2025 00:00:00 +0000

The idea of connecting a human brain directly to a computer has been a staple of science fiction for decades. But it is no longer fiction. Brain-computer interfaces, or BCIs, are real devices that translate neural activity into digital signals, and Neuralink is the company that has pushed them furthest into the public spotlight. Here is what the technology actually does, how it works, and what the road ahead looks like.

CRISPR: Editing the Source Code of Life

Sun, 02 Mar 2025 00:00:00 +0000

In 2012, two scientists published a paper that quietly changed the trajectory of modern biology. Jennifer Doudna and Emmanuelle Charpentier demonstrated that a bacterial immune system called CRISPR could be repurposed into a precise tool for editing DNA — any DNA, in any organism. Within a few years, the technique had spread to thousands of labs worldwide. By 2020, it had earned a Nobel Prize. Today, CRISPR is treating human diseases, reshaping agriculture, and forcing society to confront questions we have never had to answer before.

Lab-Grown Organs: The Race to Build Spare Parts for the Human Body

Tue, 25 Feb 2025 00:00:00 +0000

The Organ Transplant Crisis

Every day in the United States, roughly 17 people die waiting for an organ transplant. The gap between supply and demand is enormous and growing. As of early 2025, more than 100,000 Americans are on the national transplant waiting list, and globally the shortage is far worse. In many countries, organized transplant systems barely exist, and patients with failing organs simply have no options.

Longevity: Can We Hack the Biological Clock?

Wed, 19 Feb 2025 00:00:00 +0000

Aging has always been treated as an inevitability — a slow, irreversible decline written into the fabric of biology. But a growing number of scientists, billionaires, and biotech companies now treat aging as an engineering problem, one that can be measured, intervened upon, and potentially reversed. At the intersection of biology, computation, and sheer ambition, a new field is taking shape: longevity science. The question is no longer whether we can extend human lifespan, but by how much, at what cost, and who gets access.

About Us

Mon, 01 Jan 0001 00:00:00 +0000

Where biology meets the next computing revolution.

The next computing revolution isn’t just about faster silicon chips.
It’s about harnessing the extraordinary computational power already perfected by 4 billion years of evolution — living cells that self-assemble, neurons that learn in real time, and DNA that stores vast amounts of data with almost zero energy.